Detalles de la búsqueda
1.
Management of Patients with Gastric or Gastroesophageal Junction Cancer: From Theory to Integrated Clinical Path- ways Implementation in the Real World.
Clin Ter
; 173(4): 316-323, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35857048
2.
Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Ann Oncol
; 17 Suppl 7: vii73-7, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16760299
3.
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
Ann Oncol
; 17 Suppl 7: vii60-5, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16760296
4.
Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
Cancer Res
; 55(20): 4633-9, 1995 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-7553641
5.
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Ann Oncol
; 16 Suppl 4: iv56-60, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15923431
6.
Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Clin Cancer Res
; 3(6): 963-72, 1997 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9815772
7.
Subcutaneous recombinant-human-erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer.
Int J Oncol
; 1(3): 341-5, 1992 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21584553
8.
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
J Cancer Res Clin Oncol
; 120(9): 550-2, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-8045920
9.
TNF-induced apoptosis in multidrug resistant friend erythroleukemia is not influenced by the P-glycoprotein and glutathione status of the cell line.
Oncol Res
; 7(10-11): 559-64, 1995.
Artículo
en Inglés
| MEDLINE | ID: mdl-8866668
10.
Combinative growth-inhibitory effects of interferon-alpha and Doxorubicin on multidrug-resistant tumor-cell lines.
Oncol Rep
; 1(1): 161-4, 1994 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21607328
11.
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome.
Oncol Rep
; 3(3): 493-6, 1996 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21594399
12.
Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects.
Anticancer Res
; 14(6B): 2643-8, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7872695
13.
A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy.
Anticancer Res
; 14(2B): 731-4, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7516641
14.
5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Anticancer Res
; 19(2B): 1407-10, 1999.
Artículo
en Inglés
| MEDLINE | ID: mdl-10365114
15.
Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
Anticancer Res
; 19(3B): 2289-92, 1999.
Artículo
en Inglés
| MEDLINE | ID: mdl-10472346
16.
Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
Anticancer Res
; 19(4C): 3553-7, 1999.
Artículo
en Inglés
| MEDLINE | ID: mdl-10629652
17.
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
Am J Clin Oncol
; 22(3): 262-6, 1999 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-10362333
18.
Development and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches.
J Chemother
; 8(6): 465-71, 1996 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-8981188
19.
Effect of buthionine sulfoximine on the sensitivity to doxorubicin of parent and MDR tumor cell lines.
J Chemother
; 6(5): 343-8, 1994 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-7861199
20.
A phase I-II study on the toxicity and therapeutic efficacy of 5-fluorouracil in combination with leucovorin and cisplatinum in patients with advanced colorectal carcinoma.
J Chemother
; 2 Suppl 1: 28-32, 1990 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-2195135